Literature DB >> 18178823

IFN-gamma mediates the death of Th1 cells in a paracrine manner.

Kathryn E Foulds1, Masashi J Rotte, Michael A Paley, Babu Singh, Daniel C Douek, Brenna J Hill, John J O'Shea, Wendy T Watford, Robert A Seder, Chang-You Wu.   

Abstract

Th1 cells have different capacities to develop into memory cells based on their production of IFN-gamma. In this study, the mechanism by which a homogenous population of IFN-gamma-producing CD4 T cells was eliminated in vivo was assessed. When such cells were transferred into naive mice and activated with Ag, a striking decrease in the frequency of cells in the spleen and lung was observed. However, administration of neutralizing anti-IFN-gamma Ab at the time of Ag challenge largely prevented the elimination of such cells. To determine whether IFN-gamma was mediating its effects directly and/or indirectly, the ability of IFN-gamma to effectively signal in such cells was assessed in vitro. Indeed, there was reduced phosphorylation of STAT1 in response to IFN-gamma as well as markedly reduced expression of the IFN-gammaR beta-chain. Furthermore, transfer of such cells into IFN-gammaR-deficient mice limited their death following activation with Ag. Together, these data suggest that IFN-gamma acts in a paracrine manner to mediate the death of activated IFN-gamma-producing Th1 cells. In contrast to Ag stimulation, administration of CpG alone resulted in the elimination of Th1 cells in IFN-gammaR-/- mice. These results show that in response to Ag stimulation, the death of IFN-gamma-producing effector Th1 cells is controlled in an IFN-gamma-dependent manner, whereas in response to innate activation, the death of IFN-gamma-producing Th1 cells can occur through an IFN-gamma-independent pathway. Collectively, these data show the multiple mechanisms by which Th1 effector cells are efficiently eliminated in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178823     DOI: 10.4049/jimmunol.180.2.842

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance.

Authors:  Sheng Xia; Zhenhong Guo; Xiongfei Xu; Hai Yi; Quanxing Wang; Xuetao Cao
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

3.  The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death.

Authors:  Carl G Feng; Lixin Zheng; Dragana Jankovic; André Báfica; Jennifer L Cannons; Wendy T Watford; Damien Chaussabel; Sara Hieny; Patricia Caspar; Pamela L Schwartzberg; Michael J Lenardo; Alan Sher
Journal:  Nat Immunol       Date:  2008-09-21       Impact factor: 25.606

4.  T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis.

Authors:  David C Gondek; Nadia R Roan; Michael N Starnbach
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria.

Authors:  Robin Stephens; Jean Langhorne
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

Review 6.  Adoptive immunotherapy of cancer using CD4(+) T cells.

Authors:  Pawel Muranski; Nicholas P Restifo
Journal:  Curr Opin Immunol       Date:  2009-03-13       Impact factor: 7.486

7.  Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells.

Authors:  David Caretto; Shoshana D Katzman; Alejandro V Villarino; Eugenio Gallo; Abul K Abbas
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

8.  Tumor-specific Th17-polarized cells eradicate large established melanoma.

Authors:  Pawel Muranski; Andrea Boni; Paul A Antony; Lydie Cassard; Kari R Irvine; Andrew Kaiser; Chrystal M Paulos; Douglas C Palmer; Christopher E Touloukian; Krzysztof Ptak; Luca Gattinoni; Claudia Wrzesinski; Christian S Hinrichs; Keith W Kerstann; Lionel Feigenbaum; Chi-Chao Chan; Nicholas P Restifo
Journal:  Blood       Date:  2008-03-19       Impact factor: 22.113

9.  Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling.

Authors:  Horng-Ren Yang; Hong-Shuie Chou; Xiaodong Gu; Lianfu Wang; Kathleen E Brown; John J Fung; Lina Lu; Shiguang Qian
Journal:  Hepatology       Date:  2009-12       Impact factor: 17.425

10.  Antigen-free adjuvant assists late effector CD4 T cells to transit to memory in lymphopenic hosts.

Authors:  F Betul Guloglu; Jason S Ellis; Xiaoxiao Wan; Mermagya Dhakal; Christine M Hoeman; Jason A Cascio; Habib Zaghouani
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.